Compare studies and check their requirements with the research team.
This study was terminated in the United States, in Canada, and in Taiwan. It focuses on ADHD.
In United StatesThis study is completed in the United States and in Canada. It focuses on ADHD.
In United StatesThis study was terminated in the United States. It is testing PF-03463275 for schizophrenia.
In United States
This study is completed in the United States. It focuses on Depression.
In United StatesThis study is completed in the United States. It is testing psilocybin for depression.
In United StatesThis study is active but not recruiting in the United States. It is testing psilocybin for PTSD.
In United StatesThis study was terminated in the United States. It is testing rapastinel for depression.
In United StatesThis study is completed in the United States. It is testing risperidone Monotherapy for anxiety.
In United StatesThis study is completed in the United States, in Romania, in Russia, .... It is testing RO4917838 (Bitopertin) for schizophrenia.
In United StatesThis study is completed in the United States, in Canada, in Brazil, .... It is testing RO4917838 (Bitopertin) for schizophrenia.
In United StatesThis study is completed in the United States, in Bulgaria, in China, .... It is testing RO4917838 (Bitopertin) for schizophrenia.
In United StatesThis study is completed in the United States, in Canada, in Brazil, .... It is testing RO4917838 (Bitopertin) for schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.